KRO-12848

(E)-methyl 3-(dimethylamino)acrylate; 2-(3-OXOBUTYL)ISOINDOLINE-1,3-DIONE; methyl (2E)-3-(3-dimethylamino)prop-2-enoate; methyl (2E)-3-(dimethylamino)prop-2-enoate; Methyl 3-(dimethylamino)acrylate; 3-(Dimethylamino)propenoic acid methyl ester; 3-(Dimethylamino)-acrylic acid methyl ester; methyl (E)-3-(dimethylamino)acrylate; methyl E-3-(N,N-dimethylamino)-acrylate; methyl (E)-3-(dimethylamino) prop-2-enoate; Methyl 3-(N,N-Dimethylamino)Acrylate

999-59-7
98% min.
scale-up (10-1,000 kg)
C6H11NO2

KRO-45075

Cyclopropyl carboxylic acid amide; Methyl cyclopropyl carboxylic amine

105392-26-5
98% min.
scale-up (10-1,000 kg)
C14H12Cl2FNO3

KRO-38449

2-(aminomethyl)aniline; 2-Aminobenzylamine; α-Amino-o-toluidine

4403-69-4
98% min.
scale-up (10-1,000 kg)
C7H10N2

KRO-08326

(+)-Diisopinocampheyl Chloroborane; (+)-B-ChlorodiisopinocaMpheylborane; (+)-Diisopinocampheylchloroborane

112246-73-8
98% min.
scale-up (10-1,000 kg)
C20H34BCl

KRO-08327

(-)-Diisopinocampheyl chloroborane

85116-37-6
98% min.
scale-up (10-1,000 kg)
C20H34BCl

KRO-11313

(R)-5,5-Diphenyl-2-methyl-3,4-propano-1,3,2-oxazaborolidine; (R)-3,3-Diphenyl-1-methyltetrahydro-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaborole; (R)-1-methyl-3,3-diphenylhexahydropyrrolo[1,2-c][1,3,2]oxazaborole; (R)-(+)-2-Methyl-CBS-oxazaborolidine; (R)-3,3-Diphenyl-1-methylpyrrolidino[1,2-c]-1,3,2-oxazaborole

112022-83-0
98% min.
scale-up (10-1,000 kg)
C18H20BNO

KRO-10538

(S)-5,5-Diphenyl-2-Methyl-3,4-propano-1,3,2-oxazaborolidine; (S)-(-)-2-Methyl-CBS-oxazaborolidine; (3aS)-1-methyl-3,3-diphenyl-3a,4,5,6-tetrahydropyrrolo[1,2-c][1,3,2]oxazaborole; (S)-2-Methyl-CBS-oxazaborolidine; (S)-3,3-Diphenyl-1-methyltetrahydro-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaborole; (S)-Tetrahydro-1-Methyl-3,3-Triphenyl-1H,3H-Pyrrolo[1,2-c][1,3,2]Oxazaborole

112022-81-8
98% min.
scale-up (10-1,000 kg)
C18H20BNO

KRO-46862

3aR; (1S,2R)-(−)-cis-1-Amino-2-hydroxyindane; (1S,2R)-1-Amino-2,3-dihydro-1H-inden-2-ol; (1S,2R)-(−)-cis-1-Amino-2-indanol; (1S,2R)-(-)-cis-1-Amino-2,3-dihydro-1H-inden-2-ol; (1S,2R)-(-)-cis-1-Amino-2-indanol; (1S,2R)-(-)-Cis-1-Amino-2-Indanol; cis-aminoindanol; (1S,2R)-(-)-1-Amino-2-hydroxyindan; (1S,2R)-(-)-1-A

126456-43-7
98% min.
scale-up (10-1,000 kg)
C9H11NO

KRO-46978

(1R,2R)-(+)-1,2-Diphenyl-1,2-Ethanediamine ee; (1R,2R)-(+)-1,2-Diphenyl-1,2-ethanediamine; (1R,2R)-1,2-Diphenyl-1,2-ethanediamine; (1R,2R)-1,2-Diphenylethane-1,2-diamine; (1R,2R)-(+)-1,2-Diamino-1,2-diphenylethane; (1R,2R)-(+)-1,2-Diphenylethylenediamine

35132-20-8
98% min.
scale-up (10-1,000 kg)
C14H16N2

KRO-29356

n-butyryl-4-amino-3-methyl-methyl benzoate; AC-6860; 4-butyrylamino-3-methylbenzoic acid methyl ester; Benzoic acid,3-methyl-4-[(1-oxobutyl)amino]-,methyl ester; BEN178; methyl 4-(n-butyrylamino)-3-methylbenzoate; methyl N-butyryl-4-amino-3-methylbenzoate; Methyl 4-butyramido-3-methylbenzoate; Methyl4-butylacetamino-3-methylbenzoate

301533-59-5
98% min.
scale-up (10-1,000 kg)
C15H21NO3

KRO-29364

4-butyramido-3-methyl-5-nitro methyl benzoate; 4-butyrylamino-3-methyl-5-nitro-benzoic acid methyl ester; 3-Methyl-4-butyrylamido-5-nitro benzoic acid methyl ester; 4-BUTANAMIDE-3-METHYL-5-NITROBENZENE CARBOXYLATE ACID; 4-BUTANAMIDO-3-METHYL-5-NITROBENZOIC ACID

152628-01-8
98% min.
scale-up (10-1,000 kg)
C13H16N2O5

KRO-40112

4-Methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid; 4-Methyl-2-propyl-6-benzimidazolecarboxylic acid; 4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid

152628-03-0
98% min.
scale-up (10-1,000 kg)
C12H14N2O2

KRO-28221

BIP010; Telmisartan methyl ester

528560-93-2
98% min.
scale-up (10-1,000 kg)
C34H32N4O2

KRO-23295

4''-methyl-biphenyl-2-carboxylic acid; o-Tolylbenzoic acid; 2-(4-mehtylphenyl)benzoic acid; 4''-Methyl-2-carboxybiphenyl; 2-(P-TOLYL)BENZOIC ACID; o-(4-methylphenyl)benzoic acid; 2-(4-methylphenyl)benzoic acid; RARECHEM AL BO 0764; 4''-methyl-[1,1''-biphenyl]-2-carboxylic acid; 4-Methyl-2''-biphenylcarboxylic acid; 4''-Methyl-2-biphenylboronic Acid

7148-03-0
98% min.
scale-up (10-1,000 kg)
C14H12O2

KRO-41361

(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-Methoxyphenyl)diphenylMethyl)aMino)-9H-purin-9-yl)-2-((benzyloxy)Methyl)cyclopentanol; (1S,2S,3S,5S)-5-(2-((4-Methoxyphenyl)diphenylMethylaMino)-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)Methyl)cyclopentanol; Entecavir-5; Entecavir InterMediate ( # ); (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9; (1S,3R,4S)-3-(benzyloxy-5-[6-(benzyloxy)-2 -((4-Methoxyphenyl)diphenylMethylaMino) -9H-purin-9-yl]-2-(benzyloxyMethyl)cyclopentanol; Entecavir InterMediate V; (2R,3S,5S)-3-(Benzyloxy)-5-(6-benzyloxy)-2-(4-methyoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-benzyloxymethyl)cyclopentanol

142217-78-5
98% min.
scale-up (10-1,000 kg)
C52H49N5O5

KRO-17839

6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyph; I06-2209; 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine

142217-80-9
98% min.
scale-up (10-1,000 kg)
C53H49N5O4

KRO-17838

9-[(1S,3R,4S)-2-Methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-9H-Purin-2-amine; 6-(Benzyloxy)-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-9H-purine-2-amine; 6-(Benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-9H-purin-2-amine

204845-95-4
98% min.
scale-up (10-1,000 kg)
C32H31N5O3

KRO-18799

[(4R,6R)-6-(2-Amino-ethyl)-2,2-dimethyl-[1,3]dioxan-4-yl]-acetic acid tert-butyl ester; 2-[(4R,6R)-6-(2-Aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetic Acid tert-Butyl Ester; (4R-cis)-1,1-dimethylethyl-[6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate; tert-butyl [(4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate; (4R-cis)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetic acid tertiary butyl ester; ATS-9; tert-Butyl 6-aminoethyl-2,2-dimethyl-1,3-dioxolane-4-acetate; (4R,Cis)-1,1-diMethylethyl6-aMinoethyl; (4R-cis)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethylethyl ester; Atorvastatin Intermediate 1; tert-butyl [(4R,6R)-6-aminoethyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate; (4R,6R)-Tert-Butyl-6-(2-Aminoe; tert-butyl ((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-yl)acetate; 6R)-tert-Butyl-6-(2-aMinoethyl)-2; 2-diMethyl-1; tert-Butyl 2-[(4R,6R)-6-(2-Aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate; 4R,6R)-tert-Butyl-6-(2-aMinoethyl)-2,2-diMethyl-1; 3-dioxane-4-acetate; tert-butyl 2-((4R,6R)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate

125995-13-3
98% min.
scale-up (10-1,000 kg)
C14H27NO4

KRO-38373

2-Arabicyclo[2.2.1]hept-5-en-3-one; Vince''s lactam; 3-Azabicyclo[2.2.1]hepta-5-ene-2-one; 2-Azabicyclo[2.2.1]h; 4-Amino-2-cyclopentene-1-carboxylic Acid Lactam; (+/-)-2-azabicyclo[2.2.1]hept-5-en-3-one; vince lactam; Azabicyclo[2,2,1]hept-5-en-3-one; 1]hept-5-en-3-one; (+/-)-2-Azabicyclo[2.2.1]hept; 2-Azabicyclo(2,2,1,)hept-5-en-3-on; 2-Azabicyclo[2

49805-30-3
98% min.
scale-up (10-1,000 kg)
C6H7NO

KRO-49515

1,1-cyclopropane dimethanol; 5,7-Dioxa-6-Thia-Spiro[2,5]Octane-6-Oxide; 5,7-DIOXA-6-THIA-SPIRO[2,5]OCTANE 6-OXIDE; 5,7-DIOXASPIRO[2.5]OCTAN-6-ONE; 1,1-Cyclopropanedimethanol cyclic sulfite; 5.7-DIOXA-6-THIA-SPIRO[2.5]OCTANE-6-OXIDE; 1,1-CYCLOPROPANEDIMETHANOL CYCLIC SULFATE

89729-09-9
98% min.
scale-up (10-1,000 kg)
C5H8O3S